Seagen Inc.
Anti-TIGIT Antibodies

Last updated:

Abstract:

Isolated antibodies or antigen-binding portions that bind to human TIGIT (T-cell immunoreceptor with Ig and ITIM domains) are provided. In some embodiments, the antibody or antigen-binding portion thereof has a binding affinity (K.sub.D) for human TIGIT of less than 5 nM. In some embodiments, the anti-TIGIT antibody blocks binding of CD155 and/or CD112 to TIGIT.

Status:
Application
Type:

Utility

Filling date:

28 Oct 2020

Issue date:

2 Sep 2021